Inequity in cardiometabolic hospital admissions and blood screening in New Zealand Indigenous Māori with psychosis

Background People with psychosis experience worse cardiometabolic health than the same-aged general population. In New Zealand, Indigenous M & amacr;ori experiencing psychosis have greater risk of cardiometabolic and other physical health problems.Aims To identify a cohort of adults accessing secondary mental health and addiction services in New Zealand, with a previous psychosis diagnosis as of 1 January 2018, and compare odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening between M & amacr;ori and non-M & amacr;ori in the following 2 years.Method Crude and adjusted logistic regression models compared odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening (lipids and haemoglobin A1c) between M & amacr;ori and non-M & amacr;ori, occurring between 1 January 2018 and 31 December 2019.Results A cohort (N = 21 214) of M & amacr;ori (n = 7274) and non-M & amacr;ori (n = 13 940) was identified. M & amacr;ori had higher adjusted risk of mortality (odds ratio 1.26, 95% CI 1.03-1.54), and hospital admission with diabetes (odds ratio 1.64, 95% CI 1.43-1.87), cardiovascular disease (odds ratio 1.54, 95% CI 1.25-1.88) and any physical health condition (odds ratio 1.07, 95% CI 1.00-1.15) than non-M & amacr;ori. Around a third of people did not receive recommended cardiometabolic blood screening, with no difference between M & amacr;ori and non-M & amacr;ori after covariate adjustment.Conclusions M & amacr;ori experiencing psychosis are more likely to die and be admitted to hospital with cardiovascular disease or diabetes than non-M & amacr;ori. Because of the higher cardiometabolic risk borne by M & amacr;ori, it is suggested that cardiometabolic screening shortfalls will lead to worsening physical health inequities for M & amacr;ori experiencing psychosis.